Skip to main content

Peer Review reports

From: Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report

Original Submission
12 Jun 2019 Submitted Original manuscript
4 Sep 2019 Author responded Author comments - Zhaonan Liu
29 Jul 2019 Reviewed Reviewer Report - Binyong Liang
4 Aug 2019 Reviewed Reviewer Report - John Gordan
Resubmission - Version 2
4 Sep 2019 Submitted Manuscript version 2
20 Sep 2019 Author responded Author comments - Zhaonan Liu
Resubmission - Version 3
20 Sep 2019 Submitted Manuscript version 3
Publishing
24 Oct 2019 Editorially accepted
8 Nov 2019 Article published 10.1186/s12885-019-6287-8

You can find further information about peer review here.

Back to article page